Sionna Therapeutics, Inc. (SION)
↓ Download CSVKey ratios (FY2025)
-24.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$88.98M | -$70.56M | — |
| Net Income | -$75.27M | -$61.69M | — |
| EPS (Diluted) | $-1.88 | $-15.99 | — |
| Total Assets | $325.95M | $185.75M | — |
| Total Liabilities | $19.12M | $19.10M | — |
| Shareholders' Equity | $306.83M | -$163.71M | -$114.88M |
| Cash & Equivalents | $58.45M | $37.79M | — |
| Operating Cash Flow | -$66.30M | -$52.79M | — |
| Capital Expenditures | $377.0K | $27.0K | — |
| Shares Outstanding | 44.72M | 4.72M | — |